Buccal misoprostol to decrease blood loss after vaginal delivery: A randomized trial

Obstetrics and Gynecology

Volumn 104, Issue 6, 2004, Pages 1282-1288

  Bhullar, Aman ^a   Carlan, S J ^a,b   Hamm, Jennifer ^a   Lamberty, Norman ^a   White, Leigh ^a   Richichi, Kris ^a  

^a ARNOLD PALMER HOSPITAL FOR CHILDREN   (United States)

^b Orlando Regional Healthcare ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; MAGNESIUM SULFATE; MISOPROSTOL; OXYTOCIN; PLACEBO; OXYTOCIC AGENT;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD PH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HEMOGLOBIN DETERMINATION; HUMAN; INCIDENCE; LABOR; LENGTH OF STAY; MAJOR CLINICAL STUDY; PARITY; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; UMBILICAL CORD BLOOD; VAGINAL DELIVERY; BLEEDING; BUCCAL DRUG ADMINISTRATION; COMPARATIVE STUDY; DELIVERY;

ADMINISTRATION, BUCCAL; ADULT; DELIVERY, OBSTETRIC; FEMALE; HEMORRHAGE; HUMANS; MISOPROSTOL; OXYTOCICS;

EID: 16244389299     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000144119.94565.18     Document Type: Article

References (43)

1. Berg CJ, Atrash HK, Koonin LM, Tucker M. Pregnancy-related mortality in the United States, 1987-1990. Obstet Gynecol 1996;88:161-7.
2. Combs CA, Murphy EL, Laros RK. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991;77:69-76.
3. Rogers J, Wood J, McCandlish R, Ayers S, Truesdale A, Elbourn D. Active versus expectant management of third stage of labour: the Hinchingbrooke randomized controlled trial. Lancet 1998;351:693-9.
4. Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labor (Cochrane Review). In: The Cochrane Library, Issue 3, 2000. Oxford: Update Software.
5. Prendiville W, Elbourne D, Chalmers I. The effect of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials. Br J Obstet Gynecol 1988;95:3-16.
6. Nordstrom L, Fogelstam K, Fridman G, Larsson A, Rydhstroem H. Routine oxytocin in the third stage of labour: a placebo controlled randomized trial Br J Obstet Gynecol 1997;104:781-6.
7. Khan GQ, John IS, Wani S, Doherty T, Sibai BM. Controlled cord traction versus minimal intervention techniques in delivery of the placenta: a randomized controlled trial. Am J Obstet Gynecol 1997;177:770-4.
8. Takagi S, Yoshida T, Togo Y, Tochigi H, Abe M, Sakata H, et al. The effects of intramyometrial injection of prostaglandin F2alpha on severe postpartum hemorrhage. Prostaglandins 1976;12:565-79.
9. Oleen MA, Mariano JP. Controlling refractory atonic postpartum hemorrhage with Hemabate sterile solution. Am J Obstet Gynecol 1990;162:205-8.
10. Alfirevic Z, Howarth G, Gaussmann A. Oral misoprostol for induction of labor with a viable fetus (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. Oxford: Update Software.
11. Hofmeyr GJ, Gülmezoglu AM. Vaginal misoprostol for cervical ripening and labor induction in late pregnancy (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. Oxford: Update Software.
12. Hofmeyr GJ, Gülmezoglu AM, Alfirevic Z. Misoprostol for induction of labour: a systematic review. Br J Obstet Gynaecol 1999;106:798-803.
13. Carlan SJ, Blust D, O'Brien WF. Buccal misoprostol administration for cervical ripening. Am J Obstet Gynecol 2002;186:229-33.
14. el-Refaey H, O'Brien P, Morafa W, Walder J, Rodeck C. Misoprostol for third stage of labour. Lancet. 1996;347:1257.
15. el-Refaey H, O'Brien P, Morafa W, Walder J, Rodeck C. Use of oral misoprostol in the prevention of postpartum haemorrhage. Br J Obstet Gynaecol 1997;104:336-9.
16. Hofmeyr GJ, Nikodem VC, de Jager M, Gelbart BR. A randomised placebo controlled trial of oral misoprostol in the third stage of labour. Br J Obstet Gynaecol 1998;105:971-5.
17. Bamigboye AA, Hofmeyr GJ, Merrell DA. Rectal misoprostol in the prevention of postpartum hemorrhage: a placebo-controlled trial. Am J Obstet Gynecol 1998;179:1043-6.
18. Surbek DV, Fehr PM, Hösli I, Holzgreve W. Oral misoprostol for third stage of labor: a randomized placebo-controlled trial. Obstet Gynecol 1999;94:255-8.
19. Bamigboye AA, Merrell DA, Hofmeyr GJ, Mitchell R. Randomized comparison of rectal misoprostol with Syntometrine for management of third stage of labor. Acta Obstet Gynecol Scand 1998;77:178-81.
20. Cook CM, Spurrett B, Murray H. A randomized clinical trial comparing oral misoprostol with synthetic oxytocin or Syntometrine in the third stage of labour. Aust N Z J Obstet Gynecol 1999;39:414-9.
21. Amant F, Spitz B, Timmerman D, Corremans A, Van Assche FA. Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double-blind randomised trial. Br J Obstet Gynaecol 1999;106:1066-70.
22. Villar J, Gülmezoglu AM, Hofmeyr GJ, Forna F. Systematic review of randomized controlled trials of misoprostol to prevent postpartum hemorrhage. Obstet Gynecol 2002;100:1301-12.
23. Cunningham FG, Gant NF, Leveno RJ, Gilstrap LC, Hauth JC, Wenstrom KD: Obstetrical hemorrhage. In: Williams obstetrics. 21st ed. New York (NY): McGraw-Hill; 2001:635-9.
24. Jackson KW Jr, Allbert JR, Schemmer GK, Elliot M, Humphrey A, Taylor J. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage Am J Obstet Gynecol 2001;185:873-7.
25. McDonald SJ, Prendiville WJ, Blair E. Randomised controlled trial of oxytocin alone versus oxytocin and ergometrine in active management of third stage of labour. [Published erratum appears in Br Med J 1993;307:1454.] Br Med J 1993;307:1167-71.
26. McDonald SJ, Prendiville WJ, Blair E. Randomised controlled trial of oxytocin alone versus oxytocin and ergometrine in active management of third stage of labour. [Published erratum appears in Br Med J 1993;307:1454.] Br Med J 1993;307:1167-71.
27. Yuen PM, Chan NS, Yim SF, Chang AM. A randomised double blind comparison of Syntometrine and Syntocinon in the management of the third stage of labour. Br J Obstet Gynaecol 1995;102:377-80.
28. Hogerzeil HV, Walker GJ. Instability of (methyl)ergometrine in tropical climates: an overview. Eur J Obstet Gynecol Reprod Biol 1996;69:25-9.
29. Goldberg AB, Greenberg MB, Darvey PD. Misoprostol and pregnancy. N Engl J Med 2001;344:38-47.
30. Chua S, Chew SL, Yeoh CL, Roy AC, Ho LM, Selamat N, et al. A randomised controlled study of prostaglandin 15-methyl F2alpha compared with Syntometrine for prophylactic use in the third stage of labour. Aust N Z J Obstet Gynecol 1995;35:413-6.
31. Poeschmann RP, Doesburg WH, Eskes TK. A randomized comparison of oxytocin, sulprostone and placebo in the management of the third stage of labour. Br J Obstet Gynaecol 1991;98:528-30.
32. Lokugamage AU, Sullivan KR, Niculescu I, Tigere P, Onyangunga F, El-Refaey H, et al. A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for cessation of primary post partum hemorrhage. Acta Obstet Gynecol Scand 2001;80:835-9.
33. El-Refaey H, Nooh R, O'Brien P, Abdalla M, Geary M, Walder J, et al. The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management. BJOG 2000;107:1104-10.
34. Çaliskan E, Meydanli MM, Dilbaz B, Aykan B, Sönmezer M, Haberal A. Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial. Am J Obstet Gynecol 2002;187:1038-45.
35. Lumbiganon P, Villar J, Piaggio G, Gülmezoglu AM, Adetoro L, Carroli G. Side effects of oral misoprostol during the first 24 hours after administration in the third stage of labour. BJOG 2002;109:1222-6.
36. Diab KM, Ramy AR, Yehia MA. The use of rectal misoprostol as active pharmacological management of the third stage of labor. J Obstet Gynaecol Res 1999;25:327-32.
37. Karim A. Antiulcer prostaglandin misoprostol: single and multiple dose pharmacokinetic profile. Prostaglandins 1987;33(suppl):40-50.
38. Zieman M, Fong SK, Benowitz NL, Bankster D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88-92.
39. Tang OS, Schweer H, Seyberth HW, Lee WH, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002;17:332-6.
40. Dombrowski MP, Bottoms SF, Saleh AA, Hurd WW, Romero R. Third stage of labor: analysis of duration and clinical practice. Am J Obstet Gynecol 1995;172:1279-84.
41. Gülmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 2001;358:689-95.
42. Shetty A, Danielian P, Templeton A. Sublingual misoprostol for the induction of labor at term. Am J Obstet Gynecol 2002;186:72-6.
43. Çaliskan E, Dilbaz B, Meydanli MM, Ozturk N, Narin MA, Haberal A. Oral misoprostol for the third stage of labor: a randomized controlled trial. Obstet Gynecol. 2003;101:921-8.